Most Popular
-
1
NewJeans terminates contract with Ador, embarks on new journey
-
2
Ador claims exclusive contracts with NewJeans still valid
-
3
Heavy, wet snow to fall more often this winter
-
4
SNU professors join growing movement calling for Yoon's resignation
-
5
Presidential office criticizes opposition-led state auditor, prosecutor impeachment motions
-
6
N. Korea launches 32nd wave of trash balloons, anti-S. Korea leaflets
-
7
‘NewJeans are no longer under Ador,’ says legal expert
-
8
NewJeans leave for Japan shows day after unilaterally terminating contract with Ador
-
9
[From the Scene] At this Starbucks, you need ID: Franchise opens store with view of North Korea
-
10
Will Min Hee-jin reunite with NewJeans?
-
Samsung claims its wireless earbuds effective for people with hearing impairments
Samsung Electronics Co. said Monday its study showed its Galaxy Buds Pro wireless earbuds could help people with hearing impairments. The study, which was published last week in Clinical and Experimental Otorhinolaryngology (CEO), a renowned scientific journal dedicated to ear, nose and throat research, suggested that the Galaxy Buds Pro's Ambient Sound feature could assist those with mild to moderate hearing loss to better engage in conversation with others, according to Samsung. Its Ambien
March 22, 2021
-
SK Innovation’s two decades in lithium-ion battery biz
SK Innovation, the battery and new energy affiliate of SK Group, entered the battery market in 1996 and started off with large-storage lithium-ion batteries just two years later. Thanks to two decadeslong coating technologies accumulated at chemicals maker SKC, the company was able to complete world-class coating and assembly technologies for lithium-ion batteries at the time. SK’s focus was on lithium polymer batteries, making them lighter and in new form factors like the prismatic-ty
March 22, 2021
-
Naver invested 25% of revenue in R&D projects last year
Naver spent 1.33 trillion won ($1.1 billion) in research and development last year, nearly a quarter of its total annual sales, the company said Sunday. Its investment-to-sales ratio of 25.11 percent was the highest among all South Korean companies that release annual performance reports. According to the company’s annual report, its investment in R&D activities was larger than its annual operating profit last year, which was 1.2 trillion won. Compared to a year earlier, the R&D
March 21, 2021
-
Launch of Korean satellite postponed in Kazakhstan
The launch of South Korea's next-generation midsized observation satellite, slated for Saturday afternoon at a space center in Kazakhstan, has been postponed, government officials here said. The 540-kilogram satellite, loaded on Russia's Soyuz 2.1a, was scheduled to take off from the Baikonur Cosmodrome in Kazakhstan at 3:07 p.m. (11:07 a.m. local time). But the launch has been postponed, reportedly due to problems detected from the upper part of the carrier rocket, according to officials at
March 20, 2021
-
Work ban on Samsung chief Lee Jae-yong ‘unclear’: compliance committee
An external compliance monitoring committee on Samsung Electronics and its affiliates concluded on Friday that the restriction on Samsung chief Lee Jae-yong’s employment was “unclear.” The committee, led by former Chief Justice Kim Ji-hyung, discussed during its regular meeting the ongoing controversy involving the Ministry of Justice’s latest ban on Lee from being employed by Samsung for five years due to his conviction in a bribery scandal involving forme
March 19, 2021
-
Samsung BioLogics to accelerate global expansion
Samsung BioLogics, the pharmaceutical arm of Samsung Group, vowed Friday to further expand its range of drug products down the road, in a move to grow beyond the conventional antibody drug conjugate business. The blue print was delivered by CEO John Rim during the company’s 10th shareholders meeting held at the headquarters in Incheon. Rim, who was named CEO in December last year, said the company plans to secure related technologies and facilities that are capable of producing cell and
March 19, 2021
-
S. Korea set to launch next-generation observation satellite over weekend
South Korea will launch its next-generation midsized observation satellite this week, the latest in the country's efforts to boost its space industry and develop its own space technologies. The 540-kilogram satellite loaded on Russia's Soyuz 2.1a will take off from the Baikonur Cosmodrome in Kazakhstan on Saturday morning (local time) and contact the Svalbard Satellite Station in Norway after reaching its target orbit, according to the Ministry of Science and ICT. Equipped with an imaging sens
March 19, 2021
-
[News Focus] LG Group’s spinoff decision to take center stage at shareholders meeting
At the annual shareholders meeting set for next Friday, LG Group’s plans to spin off business units and create a new holding company for them are expected to take center stage. As the meeting approaches, market experts and advisory institutions are releasing their assessments of the restructuring plan, which the group says it has had in the works since the leadership change in 2018. LG Corp., the current holding company of LG Group, announced in November that the group would spin off
March 18, 2021
-
Nafabeltan out, but push for homegrown COVID-19 drug continues
The competition to develop the country’s second COVID-19 treatment continues among South Korea’s major pharmaceutical companies after Chong Kun Dang Pharmaceutical recently dropped out. South Korea’s Ministry of Food and Drug Safety announced Wednesday that it has decided not to approve Chong Kun Dang Pharmaceutical’s candidate, Nafabeltan, based on a review by its advisory board of its efficacy and safety. Chong Kun Dang Pharmaceutical’s acute pancreatitis dru
March 18, 2021
-
Daewoong clinches W380b out-licensing deal with Chinese pharmaceutical firm
Daewoong Pharmaceutical said Thursday that the company has out-licensed its gastroesophageal reflux disease agent Fexuprazan to Shanghai Haini Pharmaceutical for 380 billion won. The deal included an upfront payment of 6.8 billion won and 13.6 billion won in milestone payments, the company added. Under the agreement, Shanghai Haini has acquired rights to conduct clinical studies for the agent used to treat a digestive disorder. Shanghai Haini would also be in charge of the entire approval pr
March 18, 2021
-
S. Koreans' spending on Netflix hits over W70b in Feb.: data
South Koreans are estimated to have spent more than 70 billion won ($62.4 million) for Netflix's video streaming services last month, more than tripling from the previous year, data showed Thursday. Local credit and debit card payments on the video streaming platform reached 72.5 billion won in February, the highest-ever monthly figure, compared with 22.5 billion won the same month the previous year, according to the data from industry tacker WiseApp. Based on the data, WiseApp said there were
March 18, 2021
-
Samsung unveils most competitive midrange Galaxy A phones
Samsung Electronics is apparently shifting its focus to midrange phones from premium ones, announcing three new affordable but high-spec models on Wednesday. During its first online Galaxy Awesome Unpacked event for midrange smartphones, the South Korean smartphone vendor unveiled the Galaxy A52, A52 5G and A72 that boast optical image stabilization cameras, high-refresh rate displays and 5G for the first time among Galaxy A phones. Such a move is aimed at cementing Samsung’s top pos
March 17, 2021
-
FDA to inspect Hanmi’s drug manufacturing site in May
The US Food and Drug Administration will carry out a pre-approval inspection in May at Hanmi Pharmaceutical’s drug manufacturing facilities and packaging sites in Gyeonggi Province’s Pyeongtaek that produces the novel drug Rolontis, the Korean company said Wednesday. The US FDA was slated to approve Hanmi’s manufacturing of the given drug on Oct. 24 last year, but the schedule was temporarily shelved due to restrictions on overseas business trips amid the escalating COVID-19
March 17, 2021
-
Celltrion’s breast cancer biosimilar takes up 44% market share in Japan
South Korean biotechnology company Celltrion said Wednesday that the company‘s breast cancer drug Herzuma reached a market share of 44 percent in Japan last year. Herzuma is a biosimilar of Roche’s blockbuster breast cancer drug Herceptin (trastuzumab), used in treating patients with certain breast and gastric cancers. In the third quarter of 2019, the market share of Herzuma in Japan was just 2 percent, but the figure jumped to 12 percent in the following quarter. Herzuma&rsqu
March 17, 2021
-
S. Korean govt. initiates W600b program to nurture regenerative medicine
The South Korean government announced that it would spend 595 billion won ($525.6 million) by 2030 to support the country’s regenerative medicine sector. According to the Ministry of Science and ICT, the program will start in July this year, focused on supporting the overall research and development of regenerative medicines, exploration of related business opportunities and out-licensing of technologies. The goal is to help local firms develop at least four new regenerative medicines
March 17, 2021
-
Samsung chief’s fate in focus at shareholders meeting
SUWON, Gyeonggi Province -- Around 900 shareholders of Samsung Electronics gathered at a convention center in Suwon, Gyeonggi Province, on Wednesday to attend their 52nd annual meeting. The number of attendees more than doubled from last year, when fears of the COVID-19 pandemic hit especially hard. Samsung has hosted the shareholders meeting at the 2,000-seat Suwon Convention Center since last year. Previous meetings held at its headquarters building in Seocho-gu, southern Seoul, were ove
March 17, 2021
-
Samsung to maintain No. 1 smartphone vendor status in 2021: report
Samsung Electronics Co. is expected to defend its top status in the global smartphone market this year despite challenges from Chinese brands, a report showed Wednesday. Worldwide smartphone shipments are forecast to grow 6.5 percent on-year to 1.38 billion units in 2021, and Samsung's market share is estimated at 20 percent, unchanged from a year earlier, according to market researcher Strategy Analytics. US tech titan Apple Inc. is projected to remain second, with its market share also stayi
March 17, 2021
-
Samsung's smart TV streaming platform expands presence in 2020: report
Tizen, a Linux-based operating system developed by Samsung Electronics Co., was the top smart TV streaming platform last year, a report showed Wednesday, thanks to its status as the world's largest TV vendor. Tizen accounted for 12.7 percent of global connected TV devices in use in 2020, up from 11.6 percent a year earlier, after the number of Tizen-supporting devices increase 21 percent on-year to 162.3 million, according to industry tracker Strategy Analytics. Samsung's TV platform was follo
March 17, 2021
-
S. Korea to limit excessive payments to livestreamers
South Korea's telecommunications regulator said Wednesday it will push for a law revision to set limits on user payments to livestream broadcasters amid reports of financial damage to users that splurge on the platforms. Many video streaming platforms, including YouTube and local rival Afreeca TV, operate live payments, in which viewers can tip broadcasters in real time, serving as a form of monetization. The Korea Communications Commission (KCC) said it will pursue legal revisions to prevent
March 17, 2021
-
[Photo News] Samsung's labor union protests against 2.5% rise in annual salaries
Unionized employees at Samsung Electronics' semiconductor business protest against a 2.5 percent raise in annual salaries in the lobby of the company's headquarters in Hwaseong, Gyeonggi Province, on Tuesday. (Blind)
March 16, 2021